Surabhi Chandra

Dr. Surabhi Chandra

University of Nebraska at Kearney, Kearney, United States
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
Surabhi ChandraSurabhi Chandra
Surabhi Chandra
DFDavid J.R. Fulton
David J.R. Fulton
Robert W CaldwellRobert W Caldwell
Robert W Caldwell
HTHaroldo A. Toque
Haroldo A. Toque

30 July 2018 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
MHMegan Hunke
Megan Hunke
WMWuilian Martinez
Wuilian Martinez
AKAkshay Kashyap
Akshay Kashyap
TBTreyvon Bokoskie
Treyvon Bokoskie
MPMahesh Pattabiraman
Mahesh Pattabiraman
Surabhi ChandraSurabhi Chandra
Surabhi Chandra
Background/Aim: Breast cancer is the second leading cause of cancer-related deaths in US, which necessitates constant research for medications with minimal adverse effects. The aim of the study was to determine if certain cinnamic acid dimers (CADs) exhibit higher cytotoxicity in breast cancer cells than against non-tumorigenic cells. Materials and Methods: These dimers have not been explored, so far, due to their complex stereochemistry; cavitand-mediated photodimerization (CMP) method was used to produce several CADs, which were tested for cytotoxicity, apoptosis and cell cycle inhibition. Results: CADs such as ferulic acid dimer, 3-fluoro CAD, and 3, 4-difluoro CAD, were found to be more cytotoxic than their parent monomers. The most potent compound, 3-fluoro CAD caused apoptosis and ‘S’ phase cell cycle arrest in cancer cells. Conclusion: This study indicates an avenue for research for developing a novel class of antineoplastic compounds that can be synthesized using an easy, economical method.

1 June 2018 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
APAlaini Priebe
Alaini Priebe
MHMegan Hunke
Megan Hunke
RTRaquel Tonello
Raquel Tonello
YSYogesh Sonawane
Yogesh Sonawane
TBTemugin Berta
Temugin Berta
Surabhi ChandraSurabhi Chandra
Surabhi Chandra
Purpose: Search for alternate pain medications has gained more importance in the past few years due to adverse effects associated with currently prescribed drugs including nervous system dysfunction with opioids, gastrointestinal discomfort with nonsteroidal anti-inflammatory drugs, and cardiovascular anomalies with cyclooxygenase-2 (COX-2) inhibitors. Phytomedicine has been explored for the treatment of pain, as these have been used for generations in regional communities and tend to lack major side effects in general. One such phytomedicine, incarvillateine (INCA), derived from the Chinese herb Incarvillea sinensis has its primary antinociceptive action through the adenosine receptor, a novel pain target. We hypothesized that derivatives of cinnamic acid dimers, which are structurally similar to INCA, would show potent antinociceptive action and that their effect would be mediated through adenosine receptor action. Materials and methods: Dimers of cinnamic acid (INCA analogs) were synthesized using cavitand-mediated photodimerization (CMP) method, which utilizes a macromolecule (γ-cyclodextrin) to control excited state reactivity of photoactive compounds. Acute pain response was assessed by using formalin-induced licking behavior in hind paw of mice, and neurologic function was monitored through locomotor activity, mechanical hyperalgesia, and thermal sensitivity upon administration of test compound. For mechanistic studies, binding to adenosine receptor was determined by using computer modeling. Results: Ferulic acid dimer (FAD), which has the same chemical functionalities on the aromatic ring as INCA, showed significant suppression of formalin-induced acute pain. Antinociceptive effect was observed primarily in the inflammatory phase, and no apparent behavioral changes related to the nervous system were noticeable. Inhibition of opioid receptor did not reverse antinociceptive response, and modeling data suggest adenosine 3 receptor binding. Conclusion: FAD (INCA analog) shows potent nonopioid antinociceptive action mediated predominantly through A3AR – adenosine 3 receptor action. Further characterization and selection of such INCA analogs will help us generate a new class of antinociceptives with precise chemical modifications by using CMP methodology.

16 September 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
CCCaleb C. Capellen
Caleb C. Capellen
JOJose Ortega-Rodas
Jose Ortega-Rodas
MMM. Jane Morwitzer
M. Jane Morwitzer
HTHadassha M. N. Tofilau
Hadassha M. N. Tofilau
MDMatthew Dunworth
Matthew Dunworth
Surabhi ChandraSurabhi Chandra
Surabhi Chandra

1 April 2022 in Journal of Biological Chemistry
Verified
Journal Article
Open access
SKSmit Kour
Smit Kour
SRSandeep Rana
Sandeep Rana
SKSydney P. Kubica
Sydney P. Kubica
SKSmitha Kizhake
Smitha Kizhake
MAMudassier Ahmad
Mudassier Ahmad
ANAmarnath Natarajan
Amarnath Natarajan
The unfolded protein response (UPR) is an adaptation mechanism activated to resolve transient accumulation of unfolded/misfolded proteins in the endoplasmic reticulum. Failure to resolve the transient accumulation of such proteins results in UPR-mediated programmed cell death. Loss of tumor suppressor gene or oncogene addiction in cancer cells can result in sustained higher basal UPR levels; however, it is not clear if these higher basal UPR levels in cancer cells can be exploited as a therapeutic strategy. We hypothesized that covalent modification of surface-exposed cysteine (SEC) residues could simulate unfolded/misfolded proteins to activate the UPR, and that higher basal UPR levels in cancer cells would provide the necessary therapeutic window. To test this hypothesis, here we synthesized analogs that can covalently modify multiple SEC residues and evaluated them as UPR activators. We identified a spirocyclic dimer, SpiD7, and evaluated its effects on UPR activation signals, that is, XBP1 splicing, phosphorylation of eIF2α, and a decrease in ATF 6 levels, in normal and cancer cells, which were further confirmed by RNA-Seq analyses. We found that SpiD7 selectively induced caspase-mediated apoptosis in cancer cells, whereas normal cells exhibited robust XBP1 splicing, indicating adaptation to stress. Furthermore, SpiD7 inhibited the growth of high-grade serous carcinoma cell lines ~3-15-fold more potently than immortalized fallopian tube epithelial (paired normal control) cells and reduced clonogenic growth of high-grade serous carcinoma cell lines. Our results suggest that induction of the UPR by covalent modification of SEC residues represents a cancer cell vulnerability and can be exploited to discover novel therapeutics.

1 January 2020 in Breast Cancer: Basic and Clinical Research
Verified
Journal Article
Open access
PDF file
DDDiganta Dutta
Diganta Dutta
XPXavier-Lewis Palmer
Xavier-Lewis Palmer
JOJose Ortega-Rodas
Jose Ortega-Rodas
VBVasundhara Balraj
Vasundhara Balraj
IDIndrani Ghosh Dastider
Indrani Ghosh Dastider
Surabhi ChandraSurabhi Chandra
Surabhi Chandra
Diabetes accelerates cancer cell proliferation and metastasis, particularly for cancers of the pancreas, liver, breast, colon, and skin. While pathways linking the 2 disease conditions have been explored extensively, there is a lack of information on whether there could be cytoarchitectural changes induced by glucose which predispose cancer cells to aggressive phenotypes. It was thus hypothesized that exposure to diabetes/high glucose alters the biomechanical and biophysical properties of cancer cells more than the normal cells, which aids in advancing the cancer. For this study, atomic force microscopy indentation was used through microscale probing of multiple human breast cancer cells (MCF-7, MDA-MB-231), and human normal mammary epithelial cells (MCF-10A), under different levels of glycemic stress. These were used to study both benign and malignant breast tissue behaviors. Benign cells (MCF-10A) recorded higher Young’s modulus values than malignant cells (MCF-7 and MDA-231) under normoglycemic conditions, which agrees with the current literature. Moreover, exposure to high glucose (for 48 hours) decreased Young’s modulus in both benign and malignant cells, to the effect that the cancer cells showed a complete loss in elasticity with high glucose. This provides a possible insight into a link between glycemic stress and cytoskeletal strength. This work suggests that reducing glycemic stress in cancer patients and those at risk can prove beneficial in restoring normal cytoskeletal structure.